Antônio Márcio Santana Fernandes

Dr. Antônio Márcio Santana Fernandes

Federal University of Bahia, Salvador, Bahia, Brazil
orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 October 2022 in Clinical & Experimental Allergy
Verified
Journal Article
Closed access
Antônio Márcio Santana FernandesAntônio Márcio Santana Fernandes
Antônio Márcio Santana Fernandes
Eduardo Santos da SilvaEduardo Santos da Silva
Eduardo Santos da Silva
ESElisânia Fontes Silveira
Elisânia Fontes Silveira
EBEmília Maria Maria Medeiros de Andrade Belitardo
Emília Maria Maria Medeiros de Andrade Belitardo
LSLeonardo Freire Santiago
Leonardo Freire Santiago
CPCARINA DA SILVA PINHEIRO
CARINA DA SILVA PINHEIRO

5 July 2023 in Viruses
Verified
Journal Article
Open access
PDF file
VRVinícius Pinto Costa Rocha
Vinícius Pinto Costa Rocha
Helenita Costa QuadrosHelenita Costa Quadros
Helenita Costa Quadros
Antônio Márcio Santana FernandesAntônio Márcio Santana Fernandes
Antônio Márcio Santana Fernandes
LGLuana Pereira Gonçalves
Luana Pereira Gonçalves
RBRoberto Badaro
Roberto Badaro
Bruna MachadoBruna Machado
Bruna Machado
SARS-CoV-2 is the etiological agent of the coronavirus disease-19 (COVID-19) and is responsible for the pandemic that started in 2020. The virus enters the host cell through the interaction of its spike glycoprotein with the angiotensin converting enzyme-2 (ACE2) on the host cell’s surface. Antibodies present an important role during the infection and pathogenesis due to many reasons, including the neutralization of viruses by binding to different spike epitopes. Therefore, measuring the neutralizing antibody titers in the whole population is important for COVID-19’s epidemiology. Different methods are described in the literature, and some have been used to validate the main vaccines used worldwide. In this review, we discuss the main methods used to quantify neutralizing antibody titers, their advantages and limitations, as well as new approaches to determineACE2/spike blockage by antibodies.

13 February 2023 in Clinical & Experimental Allergy
Verified
Journal Article
Closed access
Eduardo Santos da SilvaEduardo Santos da Silva
Eduardo Santos da Silva
MSMarina Borges Rabelo de Santana
Marina Borges Rabelo de Santana
ESElisânia Fontes Silveira
Elisânia Fontes Silveira
RTRogério Tanan Torres
Rogério Tanan Torres
RSRaphael Chagas Silva
Raphael Chagas Silva
NANeuza Maria Alcantara-Neves
Neuza Maria Alcantara-Neves

14 March 2022 in Experimental and Applied Acarology
Verified
Journal Article
Closed access
PDF file
VAVítor S. Alves
Vítor S. Alves
FSFabián Salazar-Garcés
Fabián Salazar-Garcés
LSLeonardo F. Santiago
Leonardo F. Santiago
Paula FonsecaPaula Fonseca
Paula Fonseca
Antônio Márcio Santana FernandesAntônio Márcio Santana Fernandes
Antônio Márcio Santana Fernandes
CPCARINA DA SILVA PINHEIRO
CARINA DA SILVA PINHEIRO

21 February 2025 in Acta Tropica
Verified
Journal Article
Closed access
LSLeonardo F. Santiago
Leonardo F. Santiago
Eduardo Santos da SilvaEduardo Santos da Silva
Eduardo Santos da Silva
PSPriscila S. dos Santos
Priscila S. dos Santos
LGLuis F. Salazar- Garcés
Luis F. Salazar- Garcés
SSSara P.O. Santos
Sara P.O. Santos
CPCARINA DA SILVA PINHEIRO
CARINA DA SILVA PINHEIRO

18 September 2023 in Allergies
Verified
Journal Article
Open access
PDF file
CVCamilo J. B. Vieira
Camilo J. B. Vieira
RSRaphael Chagas Silva
Raphael Chagas Silva
ESElisania Fontes Silveira
Elisania Fontes Silveira
Antônio Márcio Santana FernandesAntônio Márcio Santana Fernandes
Antônio Márcio Santana Fernandes
Dumar A. Jaramillo-HernándezDumar A. Jaramillo-Hernández
Dumar A. Jaramillo-Hernández
Eduardo Santos da SilvaEduardo Santos da Silva
Eduardo Santos da Silva
(1) Background: Modification of the structural elements of allergens is widely used in the field of allergies. The goal of the present research was to express, purify, and characterize the shortened recombinant group 5 allergen of Dermatophagoides pteronyssinus (rDer p 5). (2) Methods: rDer p 5 storage stability and aggregation capacity were explored through in silico analysis, dynamic light scattering (DLS), and SDS-PAGE. Serum IgE reactivity and cytokine amount were investigated in sera or cell culture supernatants through ELISA, MULTIPLEX®, and Western blot analysis using sera from sensitized humans from Brazil, Colombia, and Ecuador. (3) Results: Dimeric rDer p 5 was detected through native PAGE, and this result was confirmed by data from DLS. The protein was thermically stable, as it did not degrade at 4 °C for 21 days. The shortened rDer p 5 was classified as a major IgE allergen in Brazil and Colombia, but minor in Ecuador. IL-13, IL-10, IL-1β, and IL-6 were significantly elevated in the sera of rDer p 5-reactive patients. The same cytokines plus IL-5 were more secreted by human cells upon rDer p 5 stimulation. (4) Conclusions: N-terminal peptide deletion led to a higher rDer p 5 folding stability, which, even though dimeric, was an IgE-reactive protein. Therefore, rDer p 5 could be used for molecular diagnostic applications or as backbone for hypoallergen design.